🔎 Trials Near Me

Akèy › Kansè tèt ak kou › South Carolina › Charleston

Etid klinik pou Kansè tèt ak kou nan Charleston, SC

8 etid pou Kansè tèt ak kou ap chèche patisipan nan sit nan ak bò kote Charleston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Ap rekriteFaz 2/3
  • Site#0104, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06788990

Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT

Ap rekrite
  • Medical University of South Carolina, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT05442957

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Ap rekriteFaz 2
  • Medical University of South Carolina Hollings Cancer Center, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07149207

The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads

Ap rekrite
  • Medical University of South Carolina, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT05811936

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 3
  • GSK Investigational Site, Charleston
Laj 18 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT06256588

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Medical University of South Carolina, Charleston
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

Ap rekrite
  • Medical University of South Carolina, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Dec 11, 2025 · NCT05793151

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Ap rekriteFaz 1
  • Medical University of South Carolina, Hollings Cancer Center, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Aug 15, 2025 · NCT04429542

Etid Kansè tèt ak kou nan lòt vil

Lòt etid nan Charleston

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.